NantHealth, Inc. (NHIQ)

OTCMKTS: NHIQ · Delayed Price · USD
0.374
-0.018 (-4.55%)
Mar 27, 2024, 12:12 PM EDT - Market closed

Total Valuation

NantHealth has a market cap or net worth of $11.04 million. The enterprise value is $279.60 million.

Market Cap 11.04M
Enterprise Value 279.60M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

NantHealth has 27.47 million shares outstanding. The number of shares has increased by 94.84% in one year.

Shares Outstanding 27.47M
Shares Change (YoY) +94.84%
Shares Change (QoQ) +94.84%
Owned by Insiders (%) n/a
Owned by Institutions (%) 4.33%
Float 7.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.17
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.35
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.08

Current Ratio 0.08
Quick Ratio 0.06
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.03

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -44.50%
Return on Capital (ROIC) -183.59%
Revenue Per Employee $176,088
Profits Per Employee -$192,803
Employee Count 365
Asset Turnover 0.41
Inventory Turnover n/a

Taxes

Income Tax -264,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.43% in the last 52 weeks. The beta is 1.53, so NantHealth's price volatility has been higher than the market average.

Beta (1Y) 1.53
52-Week Price Change -81.43%
50-Day Moving Average 0.34
200-Day Moving Average 0.42
Relative Strength Index (RSI) 48.98
Average Volume (30 Days) 3,668

Short Selling Information

The latest short interest is 37,953, so 0.14% of the outstanding shares have been sold short.

Short Interest 37,953
Short Previous Month 44,921
Short % of Shares Out 0.14%
Short % of Float 0.54%
Short Ratio (days to cover) 6.13

Income Statement

In the last 12 months, NantHealth had revenue of $64.27 million and -$70.37 million in losses. Loss per share was -$8.26.

Revenue 64.27M
Gross Profit 39.35M
Operating Income -44.44M
Pretax Income -70.64M
Net Income -70.37M
EBITDA -39.28M
EBIT -53.13M
Loss Per Share -$8.26
Full Income Statement

Balance Sheet

The company has $5.82 million in cash and $274.38 million in debt, giving a net cash position of -$268.56 million or -$9.78 per share.

Cash & Cash Equivalents 5.82M
Total Debt 274.38M
Net Cash -268.56M
Net Cash Per Share -$9.78
Equity / Book Value -250.18M
Book Value Per Share -9.11
Working Capital -175.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.64 million and capital expenditures -$4.38 million, giving a free cash flow of -$32.02 million.

Operating Cash Flow -27.64M
Capital Expenditures -4.38M
Free Cash Flow -32.02M
FCF Per Share -$2.13
Full Cash Flow Statement

Margins

Gross margin is 61.22%, with operating and profit margins of -69.14% and -109.49%.

Gross Margin 61.22%
Operating Margin -69.14%
Pretax Margin -109.90%
Profit Margin -109.49%
EBITDA Margin -61.12%
EBIT Margin -82.66%
FCF Margin -49.81%

Dividends & Yields

NantHealth does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -94.84%
Shareholder Yield -94.84%
Earnings Yield -637.24%
FCF Yield -289.92%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on December 16, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date Dec 16, 2022
Split Type Reverse
Split Ratio 1:15

Scores

NantHealth has an Altman Z-Score of -13.32 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -13.32
Piotroski F-Score 4